Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9521)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2016 (publication date) through Dec 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jarcuska P, Drazilova S, Fedacko J, Pella D, Janicko M. Association between hepatitis B and metabolic syndrome: Current state of the art. World J Gastroenterol 2016; 22(1): 155-164 [PMID: 26755867 DOI: 10.3748/wjg.v22.i1.155] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/155.htm |
| Number | Citing Articles |
| 1 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B. Revista de Gastroenterología de México 2021; 86(4): 403 doi: 10.1016/j.rgmx.2021.04.002
|
| 2 |
Ming-Whei Yu, Chih-Lin Lin, Chun-Jen Liu, Yi-Wen Huang, Jui-Ting Hu, Wan-Jung Wu, Chih-Feng Wu. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors. Journal of the Formosan Medical Association 2022; 121(8): 1478 doi: 10.1016/j.jfma.2021.10.014
|
| 3 |
Fadi ABU BAKER, Yana DAVIDOV, Areil ISRAEL, Ilan GREEN, Randa TAHER, Ziv BEN ARI, Saif ABU MOUCH. Chronic hepatitis B infection and diabetes mellitus: a double liver trouble?. Minerva Medica 2023; 114(5) doi: 10.23736/S0026-4806.23.08428-8
|
| 4 |
Ramona Maria Draguţ, Emilia Rusu, Georgiana Enache, Horaţiu Popescu, Raluca Nan, Gabriela Radulian. Liver and Metabolic Diseases. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2016; 23(1): 105 doi: 10.1515/rjdnmd-2016-0013
|
| 5 |
Telma E. Silva, Marcelo F. Ronsoni, Leonardo L. Schiavon. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(3): 431 doi: 10.1016/j.dsx.2017.12.013
|
| 6 |
Said A. Al-Busafi, Amna S. Al Balushi, Halima H. Al Shuaili, Dalia A. Mahmood, Abdullah M. Al Alawi. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study. Journal of Clinical Medicine 2024; 13(16): 4738 doi: 10.3390/jcm13164738
|
| 7 |
Julius Dongsogo, Christopher Larbie. Association of metabolic syndrome with the risk of developing liver disease in chronic hepatitis B patients. African Journal of Biochemistry Research 2019; 13(2): 23 doi: 10.5897/AJBR2017.0956
|
| 8 |
Shaohang Cai, Zejin Ou, Duan Liu, Lili Liu, Ying Liu, Xiaolu Wu, Tao Yu, Jie Peng. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome. United European Gastroenterology Journal 2018; 6(4): 558 doi: 10.1177/2050640617751252
|
| 9 |
Nam Hee Kim, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim. Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment. Digestive Diseases and Sciences 2018; 63(10): 2792 doi: 10.1007/s10620-018-5165-6
|
| 10 |
Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim. Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. Digestive Diseases and Sciences 2022; 67(7): 3412 doi: 10.1007/s10620-021-07157-1
|
| 11 |
Tomoki Sempokuya, Chun-Wei Pan, Robert J. Pattison, Chansong Choi, Akane Nogimura, Linda L. Wong. Disparities in Hepatocellular Carcinoma Outcomes Among Subgroups of Asians and Pacific Islanders: A SEER Database Study. Journal of Immigrant and Minority Health 2023; 25(4): 824 doi: 10.1007/s10903-023-01478-1
|
| 12 |
Serkan YALAKİ, Hüseyin PÜLAT. Does chronic hepatitis B infection have an impact on fasting blood glucose levels and fatty liver development?. Journal of Surgery and Medicine 2020; doi: 10.28982/josam.739568
|
| 13 |
Yan Li, Yongcheng Dong, Ziyan Huang, Qifan Kuang, Yiming Wu, Yizhou Li, Menglong Li, William B. Coleman. Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma. PLOS ONE 2017; 12(3): e0174436 doi: 10.1371/journal.pone.0174436
|
| 14 |
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis. Revista Clínica Española (English Edition) 2021; 221(10): 600 doi: 10.1016/j.rceng.2019.10.014
|
| 15 |
In Young Cho, Yoosoo Chang, Eunju Sung, Won Sohn, Jae-Heon Kang, Hocheol Shin, Seungho Ryu. Depressive symptoms and risk of liver-related mortality in individuals with hepatitis B virus infection: a cohort study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77886-2
|
| 16 |
Yao-Li Chen, Ping-Yi Lin, Ying-Zi Ming, Wei-Chieh Huang, Rong-Fu Chen, Po-Ming Chen, Pei-Yi Chu. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3460-9
|
| 17 |
Chin-Sung Kuo, Yung-Tai Chen, Chien-Yi Hsu, Chun-Chin Chang, Ruey-Hsing Chou, Szu-Yuan Li, Shu-Chen Kuo, Po-Hsun Huang, Jaw-Wen Chen, Shing-Jong Lin. The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan. BMJ Open 2017; 7(8): e016179 doi: 10.1136/bmjopen-2017-016179
|
| 18 |
Eun‐Jeong Joo, Yoosoo Chang, Seungho Ryu. Reply:. Hepatology 2017; 66(2): 682 doi: 10.1002/hep.29253
|
| 19 |
Sebastian Filippas-Ntekouan, Evangelos Liberopoulos, Moses Elisaf. Lipid testing in infectious diseases: possible role in diagnosis and prognosis. Infection 2017; 45(5): 575 doi: 10.1007/s15010-017-1022-3
|
| 20 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
| 21 |
Altansuvd Enkhtur, Joon-Sup Yoon, Chang-Woo Lee. Factors increasing the risk of mortality and morbidity due to coronavirus infection in patients with metabolic syndrome. Precision and Future Medicine 2020; 4(3): 83 doi: 10.23838/pfm.2020.00121
|
| 22 |
Caorui Lin, Qishui Ou. Emerging role of mitochondria in response to HBV infection. Journal of Clinical Laboratory Analysis 2022; 36(10) doi: 10.1002/jcla.24704
|
| 23 |
Eun-Jeong Joo, Hae Suk Cheong, Min-Jung Kwon, Won Sohn, Han-Na Kim, Yong Kyun Cho. Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00461-1
|
| 24 |
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisis. Revista Clínica Española 2021; 221(10): 600 doi: 10.1016/j.rce.2019.10.010
|
| 25 |
Scott K. Fung, Calvin Q. Pan, Grace Lai‐Hung Wong, Wai‐Kay Seto, Sang Hoon Ahn, Chi‐Yi Chen, Hie‐Won L. Hann, Maciej S. Jablkowski, Yoon Jun Kim, Cihan Yurdaydin, Cheng‐Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F. Flaherty, Leland J. Yee, Frida Abramov, Hongyuan Wang, Dzhamal Abdurakhmanov, Young‐Suk Lim, Maria Buti. Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary Pharmacology & Therapeutics 2024; 59(2): 217 doi: 10.1111/apt.17764
|
| 26 |
Han-Na Kim, Hae Suk Cheong, Bomi Kim, Won Sohn, Yong Kyun Cho, Min-Jung Kwon, Juhee Kim, Youngmi Song, Eun-Jeong Joo. Human gut microbiota from hepatitis B virus-infected individuals is associated with reduced triglyceride level in mice: faecal transplantation study. Microbes and Infection 2024; 26(3): 105281 doi: 10.1016/j.micinf.2023.105281
|
| 27 |
Ming-Whei Yu, Chih-Lin Lin, Chun-Jen Liu, Shu-Han Yang, Yu-Lin Tseng, Chih-Feng Wu. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study. Gastroenterology 2017; 153(4): 1006 doi: 10.1053/j.gastro.2017.07.001
|
| 28 |
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV Infection. Clinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
|
| 29 |
Xiaohui Zhao, Drishti Shah, Usha Sambamoorthi. Association between chronic hepatitis B infection and metabolic syndrome. Journal of Diabetes & Metabolic Disorders 2018; 17(2): 223 doi: 10.1007/s40200-018-0364-4
|
| 30 |
Jan-Hendrik Bockmann, Matin Kohsar, John M. Murray, Vanessa Hamed, Maura Dandri, Stefan Lüth, Ansgar W. Lohse, Julian Schulze-zur-Wiesch. High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. Microorganisms 2021; 9(5): 968 doi: 10.3390/microorganisms9050968
|
| 31 |
Cheng-Hung Chien, Li-Wei Chen, Chih-Lang Lin, Su-Wie Chang, Yu-Chiau Shyu, Kuan-Fu Chen, Shuo-Wei Chen, Ching-Chih Hu, Chia-Ying Yu, Rong-Nan Chien. Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based Study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10029-2
|
| 32 |
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, Ritsuzo Kozuka, Hideki Fujii, Sawako Uchida‐Kobayashi, Shinya Fukunishi, Yasuhiro Tsuda, Kazuhide Higuchi, Masaki Saito, Hirayuki Enomoto, Norifumi Kawada. Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B. Hepatology Research 2018; 48(6): 459 doi: 10.1111/hepr.13050
|
| 33 |
Fadi Abu Baker, Abdel-Rauf Zeina, Randa Taher, Saif Abu Mouch, Ariel Israel. Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study. Journal of Clinical Medicine 2024; 13(18): 5608 doi: 10.3390/jcm13185608
|
| 34 |
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis B Virus and Chronic Kidney Disease: a Systematic Review and Meta-analysis. Annals of Hepatology 2017; 16(1): 21 doi: 10.5604/16652681.1226813
|
| 35 |
Yun Soo Hong, Yoosoo Chang, Seungho Ryu, Miguel Cainzos-Achirica, Min-Jung Kwon, Yiyi Zhang, Yuni Choi, Jiin Ahn, Sanjay Rampal, Di Zhao, Roberto Pastor-Barriuso, Mariana Lazo, Hocheol Shin, Juhee Cho, Eliseo Guallar. Hepatitis B and C virus infection and diabetes mellitus: A cohort study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04206-6
|
| 36 |
James C. Barton, Jackson Clayborn Barton, Ronald T. Acton. Insulin Resistance and Metabolic Syndrome: Clinical and Laboratory Associations in African Americans Without Diabetes in the Hemochromatosis and Iron Overload Screening Study. Metabolic Syndrome and Related Disorders 2018; 16(6): 267 doi: 10.1089/met.2018.0036
|
| 37 |
Eun‐Jeong Joo, Yoosoo Chang, Joon‐Sup Yeom, Yong Kyun Cho, Seungho Ryu. Chronic hepatitis B virus infection and risk of dyslipidaemia: A cohort study. Journal of Viral Hepatitis 2019; 26(1): 162 doi: 10.1111/jvh.13014
|
| 38 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Revista de Gastroenterología de México (English Edition) 2021; 86(4): 403 doi: 10.1016/j.rgmxen.2021.04.002
|
| 39 |
Susan L Stewart, Julie HT Dang, Natalie J Török, Moon S Chen. Patterns and co-occurrence of risk factors for hepatocellular carcinoma in four Asian American communities: a cross-sectional study. BMJ Open 2019; 9(6): e026409 doi: 10.1136/bmjopen-2018-026409
|